Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema

ClinicalTrials.gov ID: NCT00367133

Public ClinicalTrials.gov record NCT00367133. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 11:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Trial Comparing Intravitreal Triamcinolone Acetonide and Laser Photocoagulation for Diabetic Macular Edema

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study involves the enrollment of patients over 18 years of age with diabetic macular edema(DME). Patients with one study eye will be randomly assigned (stratified by visual acuity and prior laser) with equal probability to one of the three treatment groups: 1. Laser photocoagulation 2. 1mg intravitreal triamcinolone acetonide injection 3. 4mg intravitreal triamcinolone acetonide injection For patients with two study eyes (both eyes eligible at the time of randomization), the right eye (stratified by visual acuity and prior laser) will be randomly assigned with equal probabilities to one of the three treatment groups listed above. The left eye will be assigned to the alternative treatment (laser or triamcinolone). If the left eye is assigned to triamcinolone, then the dose (1mg or 4 mg) will be randomly assigned to the left eye with equal probability (stratified by visual acuity and prior laser). The study drug, triamcinolone acetonide, has been manufactured as a sterile intravitreal injectable by Allergan. Study eyes assigned to an intravitreal triamcinolone injection will receive a dose of either 1mg or 4mg. There is no indication of which treatment regimen will be better. Patients enrolled into the study will be followed for three years and will have study visits every 4 months after receiving their assigned study treatment. In addition, standard of care post-treatment visits will be performed at 4 weeks after each intravitreal injection.

Study identification

NCT ID
NCT00367133
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
840 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2004 (Type not available)
Primary completion
May 2008 (Actual)
Completion
Oct 2008 (Actual)
Last update posted
Aug 26, 2016

2004 – 2008

United States locations

U.S. sites
84
U.S. states
31
U.S. cities
70
Facility City State ZIP Site status
Jones Eye Institute/University of Arkansas for Medical Sciences Little Rock Arkansas 72205-7199 —
SCPMG Regional Offices - Kaiser Permanente Baldwin Park California 91706 —
Retina-Vitreous Associates Medical Group Beverly Hills California 90211 —
University of California, Irvine Irvine California 92697 —
Loma Linda University Health Care, Dept. of Ophthalmology Loma Linda California 92354 —
Doheny Eye Institute Los Angeles California 90033 —
Jules Stein Eye Institute Los Angeles California 90095 —
Southern California Desert Retina Consultants, MC Palm Springs California 92262 —
West Coast Retina Medical Group, Inc. San Francisco California 94107 —
Orange County Retina Medical Group Santa Ana California 92705 —
California Retina Consultants Santa Barbara California 93103 —
Bay Area Retina Associates Walnut Creek California 94598 —
Denver Health Medical Center Denver Colorado 80204 —
Eldorado Retina Associates, P.C. Louisville Colorado 80027 —
Connecticut Retina Consultants New Haven Connecticut 06519-1600 —
Connecticut Retina Consultants New Haven Connecticut 06519 —
Retina Group of Florida Fort Lauderdale Florida 33334 —
National Ophthalmic Research Institute Fort Myers Florida 33912 —
Central Florida Retina Institute Lakeland Florida 33805 —
Florida Retina Consultants Lakeland Florida 33805 —
Sarasota Retina Institute Sarasota Florida 34239 —
International Eye Center Tampa Florida 33603 —
Southeast Retina Center, P.C. Augusta Georgia 30909 —
Retina Associates of Hawaii, Inc. Honolulu Hawaii 96813 —
Retina Consultants of Hawaii, Inc. ‘Aiea Hawaii 96701 —
Northwestern Medical Faculty Foundation Chicago Illinois 60611 —
Rush University Medical Center Chicago Illinois 60612 —
Illinois Retina Associates Joliet Illinois 60435 —
Raj K. Maturi, M.D., P.C. Indianapolis Indiana 46290 —
John-Kenyon American Eye Institute New Albany Indiana 47150 —
Retina and Vitreous Associates of Kentucky Lexington Kentucky 40509-1802 —
Paducah Retinal Center Paducah Kentucky 42001 —
Maine Vitreoretinal Consultants Bangor Maine 04401 —
Elman Retina Group, P.A. Baltimore Maryland 21237 —
Wilmer Ophthalmological Institute at Johns Hopkins Baltimore Maryland 21287-9277 —
The Retina Group of Washington Greenbelt Maryland 20770-3502 —
Retina Consultants of Delmarva, P.A. Salisbury Maryland 21801 —
Ophthalmic Consultants of Boston Boston Massachusetts 02114 —
Joslin Diabetes Center Boston Massachusetts 02215 —
Kresge Eye Institute Detroit Michigan 48201-1423 —
Henry Ford Health System, Dept of Ophthalmology and Eye Care Services Detroit Michigan 48202 —
Associated Retinal Consultants Grand Rapids Michigan 49546 —
Vision Research Foundation Royal Oak Michigan 48073 —
Retina Center, PA Minneapolis Minnesota 55404 —
University of Minnesota Minneapolis Minnesota 55455 —
St. Louis University Eye Institute St Louis Missouri 63104 —
Barnes Retina Institute St Louis Missouri 63110 —
Delaware Valley Retina Associates Lawrenceville New Jersey 08648 —
The New York Eye and Ear Infirmary/Faculty Eye Practice New York New York 10003 —
University of Rochester Rochester New York 14642 —
Retina Consultants, PLLC Slingerlands New York 12159 —
Retina-Vitreous Surgeons of Central New York, PC Syracuse New York 13224 —
University of North Carolina, Dept. of Ophthalmology Chapel Hill North Carolina 27599 —
Charlotte Eye Ear Nose and Throat Assoc, PA Charlotte North Carolina 28210 —
Horizon Eye Care, PA Charlotte North Carolina 28211 —
Wake Forest University Eye Center Winston-Salem North Carolina 27157 —
Retina Associates of Cleveland, Inc. Beachwood Ohio 44122 —
Case Western Reserve University Cleveland Ohio 44106 —
OSU Eye Physicians and Surgeons, LLC. Dublin Ohio 43017 —
Dean A. McGee Eye Institute Oklahoma City Oklahoma 73104 —
Retina Northwest, PC Portland Oregon 97210 —
Casey Eye Institute Portland Oregon 97239 —
Penn State College of Medicine Hershey Pennsylvania 17033 —
University of Pennsylvania Scheie Eye Institute Philadelphia Pennsylvania 19104 —
Retina Consultants Providence Rhode Island 02903 —
Palmetto Retina Center Columbia South Carolina 29169 —
Carolina Retina Center Columbia South Carolina 29223 —
Black Hills Regional Eye Institute Rapid City South Dakota 57701 —
Southeastern Retina Associates, P.C. Knoxville Tennessee 37909 —
Vanderbilt University Medical Center Nashville Tennessee 37232 —
West Texas Retina Consultants P.A. Abilene Texas 79605 —
Texas Retina Associates Arlington Texas 76012 —
Retina Research Center Austin Texas 78705 —
Texas Retina Associates Dallas Texas 75231 —
University of Texas Medical Branch, Dept of Ophthalmology and Visual Sciences Galveston Texas 77555-1106 —
Charles A. Garcia, PA & Associates Houston Texas 77002 —
Retina and Vitreous of Texas Houston Texas 77025 —
Retina Consultants of Houston, PA Houston Texas 77030 —
Texas Retina Associates Lubbock Texas 79424 —
Valley Retina Institute McAllen Texas 78503 —
Rocky Mountain Retina Consultants Salt Lake City Utah 84107 —
University of Washington Medical Center Seattle Washington 98195 —
University of Wisconsin-Madison, Dept. of Ophthalmology Madison Wisconsin 53705 —
Medical College of Wiconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00367133, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 26, 2016 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00367133 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →